Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Valentine

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonistsJohn E Tellew, Rose Ann F Baska, Sophie M Beyer, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 24, 2017
Significant Performance Enhancement of Polymer Resins by Bioinspired Dynamic BondingSungbaek Seo, Dong Woog Lee, Jin Soo Ahn, et al.
The Journal of Infectious Diseases|February 28, 2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposureJoan H Skurnick, Paul Palumbo, Anthony DeVico, et al.
Journal of Medicinal Chemistry|January 7, 2005
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokineticsNatesan Murugesan, Zhengxiang Gu, Leena Fadnis, et al.
JAMA|July 4, 2002
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trialScott M Hammer, Florin Vaida, Kara K Bennett, et al.
Nature Materials|April 1, 2022
The living interface between synthetic biology and biomaterial designAllen P Liu, Eric A Appel, Paul D Ashby, et al.
Journal of Medicinal Chemistry|August 23, 2002
Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonistsNatesan Murugesan, John E Tellew, Zhengxiang Gu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2015
Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptorGerman G Gornalusse, Srinivas Mummidi, Alvaro A Gaitan, et al.
Nature Communications|April 12, 2025
Generation of field-reversed configurations via neutral beam injectionT Roche, S Dettrick, A Fontanilla, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonistsJohn E Tellew, Rose Ann F Baska, Sophie M Beyer, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 24, 2017
Significant Performance Enhancement of Polymer Resins by Bioinspired Dynamic BondingSungbaek Seo, Dong Woog Lee, Jin Soo Ahn, et al.
The Journal of Infectious Diseases|February 28, 2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposureJoan H Skurnick, Paul Palumbo, Anthony DeVico, et al.
Journal of Medicinal Chemistry|January 7, 2005
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokineticsNatesan Murugesan, Zhengxiang Gu, Leena Fadnis, et al.
JAMA|July 4, 2002
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trialScott M Hammer, Florin Vaida, Kara K Bennett, et al.
Nature Materials|April 1, 2022
The living interface between synthetic biology and biomaterial designAllen P Liu, Eric A Appel, Paul D Ashby, et al.
Journal of Medicinal Chemistry|August 23, 2002
Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonistsNatesan Murugesan, John E Tellew, Zhengxiang Gu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2015
Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptorGerman G Gornalusse, Srinivas Mummidi, Alvaro A Gaitan, et al.
Nature Communications|April 12, 2025
Generation of field-reversed configurations via neutral beam injectionT Roche, S Dettrick, A Fontanilla, et al.
Pageof 19